Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares Issued
Ratios

Ligand Pharmaceuticals (LGND) Long-Term Debt Issuances: 2011-2022

  • Ligand Pharmaceuticals' Long-Term Debt Issuances fell 90.30% to $202,000 in Q3 2022 from the same period last year, while for Sep 2022 it was $31.5 million, marking a year-over-year decrease of 18.79%. This contributed to the annual value of $202,000 for FY2022, which is 98.93% down from last year.
  • Ligand Pharmaceuticals' Long-Term Debt Issuances amounted to $202,000 in Q3 2022, which was down 90.30% from $2.1 million recorded in Q3 2021.
  • Ligand Pharmaceuticals' Long-Term Debt Issuances' 5-year high stood at $16.9 million during Q1 2021, with a 5-year trough of $202,000 in Q3 2022.
  • Over the past 2 years, Ligand Pharmaceuticals' median Long-Term Debt Issuances value was $2.1 million (recorded in 2021), while the average stood at $6.4 million.
  • Data for Ligand Pharmaceuticals' Long-Term Debt Issuances shows a maximum YoY slumped of 90.30% (in 2022) over the last 5 years.
  • Ligand Pharmaceuticals' Long-Term Debt Issuances (Quarterly) stood at $12.4 million in 2019, then reached $2.1 million in 2021, then slumped by 90.30% to $202,000 in 2022.
  • Its Long-Term Debt Issuances stands at $202,000 for Q3 2022, versus $2.1 million for Q3 2021 and $16.9 million for Q1 2021.